SCHEMBL782192

SCHEMBL782192

O=C(/C=C/c1ccc(O)cc1)CCN1CCOCC1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 2/20 0.76
AKR1B10 O60218 1/20 0.53
AKR1B1 P15121 1/20 0.53
MAOB P27338 1/20 0.53
PTGS2 P35354 1/20 0.53
GLO1 Q04760 1/20 0.53
CAMK2A Q9UQM7 1/20 0.53
HDAC3 O15379 1/20 0.49
HDAC4 P56524 1/20 0.49
HDAC1 Q13547 1/20 0.49
HDAC7 Q8WUI4 1/20 0.49
HDAC2 Q92769 1/20 0.49
HDAC10 Q969S8 1/20 0.49
HDAC11 Q96DB2 1/20 0.49
HDAC8 Q9BY41 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49
HDAC9 Q9UKV0 1/20 0.49
HDAC5 Q9UQL6 1/20 0.49
ATM Q13315 1/20 0.49
MAPT P10636 4/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL782193 1.00 HSP90AA1 (0.76) HSP90AA1AKR1B10AKR1B1MAOBPTGS2
Hydrochloric Acid SCHEMBL11197008 0.99 HSP90AA1 (0.78) HSP90AA1AKR1B10AKR1B1MAOBPTGS2
Hydrochloric Acid SCHEMBL11197002 0.99 HSP90AA1 (0.78) HSP90AA1AKR1B10AKR1B1MAOBPTGS2
SCHEMBL780338 0.88 HSP90AA1 (0.74) HSP90AA1MAOBHDAC3HDAC4HDAC1
SCHEMBL780339 0.88 HSP90AA1 (0.74) HSP90AA1MAOBHDAC3HDAC4HDAC1
SCHEMBL782305 0.87 HSP90AA1 (0.97) HSP90AA1MAOBMAPTALDH1A1KMT2A
SCHEMBL782304 0.87 HSP90AA1 (0.97) HSP90AA1MAOBMAPTALDH1A1KMT2A
Hydrochloric Acid SCHEMBL11197407 0.86 HSP90AA1 (0.76) HSP90AA1HDAC3HDAC4HDAC1HDAC7
Hydrochloric Acid SCHEMBL11121413 0.86 HSP90AA1 (0.76) HSP90AA1MAOBHDAC3HDAC4HDAC1
Hydrochloric Acid SCHEMBL11197403 0.86 HSP90AA1 (0.76) HSP90AA1HDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250041255-A1 COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE SKIN DISEASES YALE UNIVERSITY 2025-02-06 US disclosed
US-10881656-B2 HIF inhibitors and use thereof THE GENERAL HOSPITAL CORPORATION (US) 2021-01-05 US disclosed
US-20170157111-A1 HIF INHIBITORS AND USE THEREOF THE GENERAL HOSPITAL CORPORATION (US) 2017-06-08 US disclosed
US-9604958-B2 HIF inhibitors and use thereof THE GENERAL HOSPITAL CORPORATION (US) 2017-03-28 US disclosed
US-20150023868-A1 HIF INHIBITORS AND USE THEREOF THE GENERAL HOSPITAL CORPORATION (US) 2015-01-22 US disclosed
US-20120070369-A1 HIF INHIBITORS AND USE THEREOF THE GENERAL HOSPITAL CORPORATION (US) 2012-03-22 US disclosed
WO-2010068794-A2 HIF INHIBITORS AND USE THEREOF THE GENERAL HOSPITAL CORPORATION (US) 2010-06-17 WO disclosed
US-4400380-A HERBES VIRUS; TOPICAL MERRELL DOW PHARMACEUTICALS INC. (US) 1983-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10881656-B2 HIF inhibitors and use thereof HIF1AN, HIF1A, EGLN3 HSP90AA1 110/4885AKR1B10 1475/4885AKR1B1 533/4885
US-20120070369-A1 HIF INHIBITORS AND USE THEREOF HIF1AN, HIF1A, EGLN3 HSP90AA1 110/4885AKR1B10 1475/4885AKR1B1 533/4885
US-20150023868-A1 HIF INHIBITORS AND USE THEREOF HIF1AN, HIF1A, EGLN3 HSP90AA1 110/4885AKR1B10 1475/4885AKR1B1 533/4885
US-20250041255-A1 COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE SKIN DISEASES HIF1AN, HIF1A, SSB HSP90AA1 918/4885AKR1B10 4227/4885AKR1B1 4041/4885
US-20170157111-A1 HIF INHIBITORS AND USE THEREOF HIF1AN, HIF1A, EGLN3 HSP90AA1 110/4885AKR1B10 1475/4885AKR1B1 533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.